Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AEM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Applied and Environmental Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About AEM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Food Microbiology

Antiproliferative Effects of Homogenates Derived from Five Strains of Candidate Probiotic Bacteria

Tanja Pessi, Yelda Sütas, Maija Saxelin, Harri Kallioinen, Erika Isolauri
Tanja Pessi
Department of Pediatrics, University of Turku, Turku, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yelda Sütas
Department of Pediatrics, University of Turku, Turku, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maija Saxelin
Valio Ltd., Research and Development Centre, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harri Kallioinen
Valio Ltd., Research and Development Centre, Helsinki, Finland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erika Isolauri
Department of Pediatrics, University of Turku, Turku, and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/AEM.65.11.4725-4728.1999
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Unheated and heat-treated homogenates were separately prepared from candidate probiotic bacteria, including Lactobacillus rhamnosus GG, Bifidobacterium lactis,Lactobacillus acidophilus, Lactobacillus delbrueckii subsp. bulgaricus, andStreptococcus thermophilus. We compared the phytohemagglutinin-induced proliferation of mononuclear cells in the presence of homogenates and in the presence of a control containing no homogenate by assessing thymidine incorporation in cell cultures. All homogenates suppressed proliferation, whether the enzymatic activity was inactivated or not inactivated by heating. When the proliferation assays were repeated with cytoplasmic and cell wall extracts derived from the homogenate of L. rhamnosus GG, the cytoplasmic extract but not the cell wall extract was suppressive. These findings indicate that candidate probiotic bacteria possess a heat-stable antiproliferative component(s). These bacteria may be used to generate microbiologically nonviable yet immunologically active probiotic food products that are easier to store and have a longer shelf life.

In the generation of novel functional foods with probiotics, an understanding of the mechanisms of probiotic action is crucial. Probiotics are defined as live microbial food ingredients which are beneficial to the health of their hosts (24). The most frequently used probiotic bacteria are lactic acid bacteria and bifidobacteria. Data on probiotic bacteria imply that they have both up- and downregulatory effects on immune responses. It has been shown that in vitro live probiotic bacteria potentiate nonspecific immunity by stimulating cytokine production (16, 18), which is beneficial in eradication of pathogens. Orally administered live probiotic bacteria have been shown to suppress intestinal inflammation in vivo (15) and thus are useful in controlling hypersensitivity reactions.

Suppression of inflammatory reactions to ubiquitous antigens is essential for the maintenance of physiological immune homeostasis (30). As the antigens are processed and induce specific systemic hyporesponsiveness, reexposure to them does not elicit hypersensitivity reactions (21, 30). Performing proliferation assays of lymphoid blood cells is a means of studying hypersensitivity to the antigens in question. The use of a mitogen as an antigen allows workers to study the modulation of nonspecific immune responses (14).

In a number of studies workers have described the immunomodulatory effects of nonviable forms of probiotic bacteria (5, 16, 18, 26, 27, 29). However, no study has dealt with differences between homogenates derived from candidate probiotic bacteria in relation to regulation of immune responses. The objective of the present study was to characterize the immunomodulatory effects of homogenates, with or without inactivation of their enzymes, obtained fromLactobacillus rhamnosus GG, Bifidobacterium lactis, Lactobacillus acidophilus, Lactobacillus delbrueckii subsp. bulgaricus, and Streptococcus thermophilus by using a mitogen-induced proliferation test in vitro. In addition, we performed a series of experiments to locate the immunomodulatory component(s) by fractionating the homogenates into cytoplasmic and cell wall extracts.

MATERIALS AND METHODS

Microorganisms. L. rhamnosus GG ATCC 53103, L. acidophilus NCFB 1748, and L. delbrueckii subsp.bulgaricus ATCC 11842 were grown anaerobically in MRS broth (Lab M, Bury, United Kingdom) at 37°C for 13 h. B. lactis BB12 (Chr. Hansen, Horsholm, Denmark) was cultured anaerobically at 37°C for 22 h in MRS broth (Lab M), andS. thermophilus DSM 4022 was cultured anaerobically at 37°C for 13 h in whey permeate broth containing 5% whey permeate (Valio Ltd., Research and Development Centre, Helsinki, Finland), 2% casein hydrolysate (Valio Ltd.), and 1% yeast extract (Lab M). All strains were kindly provided by T. Suomalainen (Valio Ltd.). The organisms were harvested by centrifugation and washed three times with 0.1 M phosphate buffer (pH 6.9).

Preparation of bacterial homogenates.Bacterial homogenates were isolated as previously described, with minor modifications (8). Briefly, the contents of bacterial cells were released by sonication with an Ultrasonic 1000 sonicator (B. Braun Biotech International Gmbh, Melsungen, Germany) on ice at 30-s intervals until the cells were disrupted. The degree of cell breakage was estimated, and the cell numbers were calculated by using light microscopy; the number of ruptured cells was determined by counting the intact cells before and after sonication and subtracting the number before sonication from the number after sonication. Each of the preparations was then suspended in 0.1 M phosphate buffer (pH 6.9) in order to equalize differences in the numbers of ruptured cells for the bacterial strains (108 cells/ml). Finally, the preparations were centrifuged at 1,000 × g for 30 min at 4°C, and each supernatant obtained, which was used as a homogenate, was stored at −70°C until it was used.

Preparation of cytoplasm and cell wall extracts of L. rhamnosus GG.The L. rhamnosus GG homogenate was recentrifuged at 35,000 × g for 20 min at 4°C in order to obtain cell wall extracts in the pellet fraction and cytoplasm in the supernatant fraction. The cell wall extract was prepared from the pellet by suspension in 0.1 M phosphate buffer (pH 6.9) so that an amount equal to the amount of the supernatant was obtained. The samples were stored at −70°C until they were used.

Measurement of enzyme activity.The enzyme activities of homogenates and extracts were measured by measuring protease activities as previously described, with minor modifications (1). Briefly, a homogenate was incubated with 0.15 mg of whey protein hydrolysate 80 LH (Valio Ltd.; low-heat-treated protein content, 80%; α-aminonitrogen content of total nitrogen, 30%) in 1 ml of phosphate buffer for 2 h at 37°C. Hydrolysis was stopped by adding 0.75 N trichloroacetic acid (Baker, Deventer, Holland). α-Amino groups released by hydrolysis reacted with o-phthaldialdehyde (FLUKA-Chemie Ag, Buchs, Switzerland) and β-mercaptoethanol (FLUKA-Chemie Ag) to form an adduct which absorbed strongly at 340 nm. Enzymatic activity was calculated by using tyrosine as the standard. This compound was destroyed by heating at 75°C for 15 min. This was confirmed by using a previously described method, with minor modifications (1).

Dilutions.Two sets of test dilutions were prepared from unheated homogenates. In the first set, homogenates were diluted 1:10, 1:100, and 1:1,000 based on the number of ruptured cells per 1 ml of preparation; in the second, homogenates were diluted 1:10, 1:100, and 1:1,000 based on their enzymatic activities.

One set of dilutions was prepared from heat-treated homogenates. The homogenates were diluted 1:10, 1:100, and 1:1,000 based on the number of ruptured cells per 1 ml of preparation.

One set of dilutions was prepared from unheated and heat-treated cytoplasmic extracts and the corresponding cell wall extracts. The extracts were diluted 1:10, 1:100, and 1:1,000 based on the number of ruptured cells per 1 ml of preparation.

All of the preparations were filtered (Millex-GV; pore size, 0.22 μm; Nihon Millipore Kogyo Inc., Yonezawa, Japan) and added to cell cultures.

Proliferation assay.A proliferation assay was used to measure mononuclear cell responses to antigens (14). The mitogen used, phytohemagglutinin (PHA; Difco Laboratories, Detroit, Mich.), mimics an antigen and induces T cell activation and replication (14). For the assay, leukocyte-rich buffy coat blood was obtained from 15 healthy donors (Finnish Red Cross Blood Transfusion Service, Turku, Finland). Peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll-Paque (Pharmacia Fine Chemicals AB, Uppsala, Sweden) density gradient centrifugation, and cell viability was assessed by trypan blue exclusion. A total of 106 cells were suspended in 1 ml of complete Roswell Park Memorial Institute 1640 culture medium (GIBCO BRL Inc., Life Technologies, Paisley, Scotland) supplemented with 10% fetal calf serum, 10 mM HEPES buffer, 2 mMl-glutamine (GIBCO BRL Inc.), 50 U of benzylpenicillin (Sigma Chemical Co., St. Louis, Mo.), and 10 mg of gentamicin (Roussel Laboratories Ltd., Uxbridge, Middlesex, United Kingdom). Dilutions of the preparations studied were confirmed to be nontoxic to cells by dye exclusion studies performed with eosin. Proliferation was tested by adding the mitogen PHA to a final concentration of 125 μg/ml together with one of the preparations in one of three dilutions. Control cell cultures contained only PHA. Triplicate cell cultures were incubated in 96-well flat-bottom plates (Nunc, Roskilde, Denmark) for 96 h at 37°C in a humidified 5% CO2 atmosphere. [3H]thymidine (0.5 μCi/well; specific activity, 2.0 Ci/mmol/ml; Radiochemical Centre, Amersham, United Kingdom) was added 18 h before harvesting with an automatic harvester (Harvester 96, Mach III M, TOMTEC; Wallac Ltd., Turku, Finland). [3H]thymidine incorporation was estimated by using a liquid scintillation counter (model 1450 Microbeta PLUS; Wallac Ltd.), and data were expressed as counts per minute with the background value excluded.

Statistical analyses.Data are presented below as medians (interquartile ranges) based on 6 to 15 experiments. Friedman’s nonparametric analysis of variance (3) was used to compare six experiments, five performed with homogenates and one performed with a control cell culture. Wilcoxon’s matched pairs test (2) was used in pairwise comparisons of heat-treated and unheated strains and in comparisons of cellular components and control cell cultures.

RESULTS

Suppression of mitogen-induced proliferation by unheated homogenates.Initially, we compared unheated homogenates from five bacterial strains with the control culture. Figure1 shows the mitogen-induced proliferation of PBMCs in homogenates at a dilution of 1:10 and in control cultures. There were significant differences among the proliferation results obtained in the six experiments (P < 0.001, as determined by Friedman’s test). The most potent suppression of proliferation was observed with L. rhamnosus GG homogenate. As shown in Fig. 2, dilution of the homogenate gradually reduced the antiproliferative effect.

Fig. 1.
  • Open in new tab
  • Download powerpoint
Fig. 1.

Mitogen-induced proliferative responses of PBMCs to unheated homogenates of L. rhamnosus GG, B. lactis, L. acidophilus, L. delbrueckiisubsp. bulgaricus, and S. thermophilus at a dilution of 1:10 and to a control culture. The results are expressed in counts per minute; the boxes indicate the lower and upper quartiles, and each central point is the median. The upper end of each bar is the maximum value, and the lower end is the minimum value (n = 8 for each study group). L. GG,L. rhamnosus GG; L. bulgaricus, L. delbrueckii subsp. bulgaricus.

Fig. 2.
  • Open in new tab
  • Download powerpoint
Fig. 2.

Mitogen-induced proliferative responses of PBMCs to unheated homogenates of L. rhamnosus GG at three dilutions (1:1,000, 1:100, and 1:10) and to a control culture. The results are expressed in counts per minute; the boxes indicate the lower and upper quartiles, and each central point is the median. The upper end of each bar is the maximum value, and the lower end is the minimum value (n = 15 for each study group). L. GG.,L. rhamnosus GG.

The effect of enzymatic activity on the proliferation rate was evaluated separately. The enzymatic activities in the preparations studied varied between 12 and 137 nmol · ml−1· min−1. After dilution, each homogenate contained the same enzymatic activity. Table 1 shows the mitogen-induced proliferation of PBMCs in homogenates diluted 1:10 and in control cultures. The differences among the results of the six experiments were statistically significant (P < 0.001, as determined by Friedman’s test). Potent suppression of proliferation compared with the control was observed with L. rhamnosus GG,B. lactis, L. acidophilus, and L. delbrueckii subsp. bulgaricus but not withS. thermophilus when the preparation was diluted to the same enzymatic activity level as the other bacterial preparations.

View this table:
  • View inline
  • View popup
Table 1.

Effects of unheated homogenates from L. rhamnosus GG, B. lactis, L. delbrueckiisubsp. bulgaricus, L. acidophilus, andS. thermophilus on mitogen-induced proliferation of PBMCs when the homogenates were equalized on the basis of their enzymatic activities

Suppression of mitogen-induced proliferation by heat-treated homogenates.In order to assess the effect of inactivation of enzymes of probiotic bacteria on proliferation, homogenates were heat treated and enzyme inactivation was confirmed. The homogenates were then added to cultures diluted based on the number of ruptured cells per ml of preparation. Figure 3 shows the mitogen-induced proliferation of PBMCs in the homogenates at a 1:10 dilution and in control cultures. Significant differences in proliferation were observed in the six experiments (P < 0.001, as determined by Friedman’s test).

Fig. 3.
  • Open in new tab
  • Download powerpoint
Fig. 3.

Mitogen-induced proliferative responses of PBMCs to heat-treated homogenates of L. rhamnosus GG,B. lactis, L. acidophilus, L. delbrueckii subsp. bulgaricus, and S. thermophilus at a dilution of 1:10 and to a control culture. The results are expressed in counts per minute; the boxes indicate the lower and upper quartiles, and each central point is the median. The upper end of each bar is the maximum value, and the lower end is the minimum value (n = 7 for each study group).L. GG., L. rhamnosus GG; L. bulgaricus, L. delbrueckii subsp.bulgaricus.

Heat treatment of homogenates significantly reduced but did not eliminate the suppressive effects of L. rhamnosus GG andL. acidophilus. In the experiment performed with control culture, the median (interquartile range) mitogen-induced proliferation was 30,381 cpm (15,625 to 35,340 cpm). The levels of proliferation in unheated and heat-treated homogenates of L. rhamnosus GG were 1,755 cpm (602 to 3,670 cpm) and 5,482 cpm (3,138 to 8,609 cpm) (P = 0.017, as determined by Wilcoxon’s matched pairs test), respectively, and the levels of proliferation in L. acidophilus homogenates were 8,074 cpm (2,288 to 15,645 cpm) and 13,108 cpm (7,967 to 21,939 cpm) (P = 0.018, as determined by Wilcoxon’s matched pairs test), respectively.

Effects of L. rhamnosus GG cytoplasmic and cell wall extracts on mitogen-induced proliferation.Figure4 shows the mitogen-induced proliferation of PBMCs in unheated and heat-treated L. rhamnosus GG cytoplasmic and cell wall extracts at a 1:10 dilution and in control cultures. Both unheated and heat-treated cytoplasmic extracts significantly suppressed mitogen-induced proliferation compared with the control (P = 0.018 and P = 0.018, respectively, as determined by Wilcoxon’s matched pairs test). Cell wall extract did not modify proliferation. Heat treatment slightly interfered with the suppressive effect of cytoplasmic extract; the median (interquartile range) mitogen-induced proliferation in heat-treated cytoplasmic extracts and in unheated cytoplasmic extracts were 3,308 cpm (53 to 11,383 cpm) and 473 cpm (91 to 3,319 cpm) (P = 0.062, as determined by Wilcoxon’s matched pairs test), respectively.

Fig. 4.
  • Open in new tab
  • Download powerpoint
Fig. 4.

Mitogen-induced proliferative responses of PBMCs to unheated (open bars) (n = 8) and heat-treated (solid bars) (n = 7) cytoplasmic and cell wall extracts ofL. rhamnosus GG at a dilution of 1:10 and to a control culture. The results are expressed in counts per minute; the boxes indicate the lower and upper quartiles, and each central point is the median. The upper end of each bar is the maximum value, and the lower end is the minimum value.

DISCUSSION

Our finding that homogenates derived from L. rhamnosusGG, B. lactis, L. acidophilus, L. delbrueckii subsp. bulgaricus, and S. thermophilus suppress mitogen-induced proliferation of PBMCs suggests that such homogenates could be used in controlling hypersensitivity reactions. Homogenates of these organisms appeared to have similar antiproliferative components. Differences in the levels of suppression may arise from the proportions of these components in specific probiotic strains.

Commensal and pathogenic bacteria differ in terms of their action on immune cells in the gut (7, 12, 17). Bacteria and bacterial homogenates of the commensal gut microflora do not stimulate proliferation of mononuclear cells (7) and play an important role in the maintenance of hyporesponsiveness to foreign antigens (19). Pathogens, in contrast, activate mucosal immune cells and result in the proliferation of these cells, triggering an inflammatory reaction (7, 12). The strains which we studied,L. rhamnosus GG ATCC 53103, B. lactis BB12,L. acidophilus NCFB 1748, L. delbrueckii subsp.bulgaricus ATCC 11842, and S. thermophilus DSM 4022, were found to suppress proliferation. This phenomenon may be attributed to the fact that L. rhamnosus GG ATCC 53103,B. lactis BB12, and L. acidophilus NCFB 1748 belong to the healthy human flora (10, 22, 25). Likewise, the yogurt organisms L. delbrueckii subsp.bulgaricus and S. thermophilus have been shown to share properties with microflora strains found in healthy humans (5, 6, 20, 23, 28, 29). Here we demonstrated that homogenates from these candidate probiotic bacteria suppress immune responses in vitro, a property associated with the function of commensal microflora rather than pathogenic bacteria in the gut.

Viability and survival in the gastrointestinal tract have been considered essential properties of probiotic bacteria (24). It is expected that most bacteria encountered via the enteric route will be disrupted, their cell walls will be broken, and their cell contents will be released (4). Proteases of intestinal bacteria are capable of hydrolyzing luminal proteins into peptides (9), rendering immune cells inert to such proteins, as a part of the natural immune defense (21). In this manner, it is plausible that proteases in homogenates interfere with cell viability during proliferation.

However, the proteases present in preparations are not directly associated with suppression of mitogen-induced proliferation. First, cell viability, as assessed in this study by microscopic evaluation, was not influenced by the addition of preparations containing enzymatic activity. Second, equalization of homogenates on the basis of their enzymatic activities did not result in comparable immunosuppressive activities. Third, heat treatment (i.e., inactivation of proteases) reduced but did not eliminate the suppressive effect of the homogenates. Thus, we concluded that enzyme activity contributes to the suppressive activity of probiotic bacteria; the major mediator of the suppressive effect appears to be the amount of heat-stable bacterial products released from broken cells.

Judging from our findings, the components in homogenates considered to be responsible for immunosuppressive effects are located in the cytoplasm, not in the cell wall. It has been suggested previously that bacterial cell wall and cytoplasmic components modulate the action of immune cells via their receptors (6, 28). More recently, oral ingestion of cytoplasmic fractions of probiotic bacteria has resulted in enhancement of immunoglobulin A responses; this finding is similar to findings obtained after oral supplementation with live probiotic bacteria (11, 13, 26, 27). Furthermore, the antiproliferative effects of the homogenates which we studied confirm previous findings which indicated that probiotic bacteria are involved in the suppression of cytokine production by T cells (28) and thereby help in the generation of T-cell-mediated systemic hyporesponsiveness (30). The precise mechanisms by which these immunomodulatory components operate remain to be investigated.

In summary, the immunomodulatory effects of candidate probiotic strains were associated not only with live microorganisms (in fact, this is the definition of probiotics) but also with nonviable organisms. The use of nonviable probiotics should result in longer shelf life and easier storage. The possible use of probiotic homogenates as components of functional foods must be studied further, and clinical studies are in progress to validate the acceptability of such organisms.

ACKNOWLEDGMENTS

This work was supported by the Academy of Finland.

We thank Mikko Hurme for advice during the study and Tuija Poussa for statistical consultation.

FOOTNOTES

    • Received 14 April 1999.
    • Accepted 7 August 1999.
  • Copyright © 1999 American Society for Microbiology

REFERENCES

  1. 1.↵
    1. Church F. C.,
    2. Swaisgoo H. E.,
    3. Porter D. H.,
    4. Catign G. L.
    Spectrophotometric assay using o-phthaldialdehyde for determination of proteolysis in milk and isolated milk proteins. J. Dairy Sci. 66 1983 1219 1227
    OpenUrlCrossRefWeb of Science
  2. 2.↵
    1. Conover W. J.
    The one sample or matched pairs case: the Wilcoxon signed ranks test Practical nonparametric statistics. Conover W. J. 1980 280 288 John Wiley & Sons, Inc. New York, N.Y
  3. 3.↵
    1. Conover W. J.
    The one sample or matched pairs case: the Friedman test Practical nonparametric statistics. Conover W. J. 1980 299 309 John Wiley & Sons, Inc. New York, N.Y
  4. 4.↵
    1. Conway P. L.,
    2. Gorbach S. L.,
    3. Goldin B. R.
    Survival of lactic acid bacteria in the human stomach and adhesion to intestinal cells. J. Dairy Sci. 70 1987 1 12
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. De Simone C.,
    2. Vasely R.,
    3. Nergi R.,
    4. Bianchi-Salvadori B.,
    5. Zanzoglu S.,
    6. Cilli A.,
    7. Lucci L.
    Enhancement of immune response of murine Peyer’s patches by a diet supplemented with yogurt. Immunopharmacol. Immunotoxicol. 9 1987 87 100
    OpenUrlPubMed
  6. 6.↵
    1. De Simone C.,
    2. Grassi P. P.,
    3. Bianchi-Salvadori B.,
    4. Miragliotta G.,
    5. Vasely R.,
    6. Jirillo E.
    Adherence of specific yogurt micro-organisms to human peripheral blood lymphocytes. Microbios 55 1988 49 57
    OpenUrlPubMed
  7. 7.↵
    1. Duchman R.,
    2. Kaiser I.,
    3. Hermann E.,
    4. Mayet W.,
    5. Ewe K.,
    6. Meyer zum Büschenfeld K. H.
    Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease. Clin. Exp. Immunol. 102 1995 448
    OpenUrlPubMedWeb of Science
  8. 8.↵
    1. Exerkate F. A.,
    2. Veer G. J. C. M.
    Partial isolation and degradation of caseins by cell wall proteinase(s) of Streptococcus cremoris HP. Appl. Environ. Microbiol. 49 1985 328 332
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Gibson S. A. W.,
    2. McFarlan C.,
    3. Hay S.,
    4. Macfarlane G. T.
    Significance of microflora in proteolysis in the colon. Appl. Environ. Microbiol. 55 1989 679 683
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Goldin B. R.,
    2. Goldin S. L.,
    3. Saxelin M.,
    4. Barakat S.,
    5. Gualtieri L.,
    6. Salminen S.
    Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 37 1992 121 128
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Isolauri E.,
    2. Majamaa H.,
    3. Arvola T.,
    4. Rantala I.,
    5. Arvilommi H.
    Lactobacillus strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology 105 1993 1643 1650
    OpenUrlPubMedWeb of Science
  12. 12.↵
    1. Jiang Y.,
    2. Magli L.,
    3. Russo M.
    Bacterium-dependent induction of cytokines in mononuclear cells and their pathogenic consequences in vivo. Infect. Immun. 67 1999 2125 2130
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Kaila M.,
    2. Isolauri E.,
    3. Saxelin M.,
    4. Arvilommi H.,
    5. Vesikari T.
    Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch. Dis. Child. 72 1995 51 53
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Kirkpatrick C. H.
    Lymphocyte transformation test Encyclopedia of immunology. Roitt I. V., Delves P. J. 1992 1005 1008 Academic Press New York, N.Y
  15. 15.↵
    1. Majamaa H.,
    2. Isolauri E.
    Probiotics: novel approach in management of food allergy. J. Allergy Clin. Immunol. 99 1996 179 185
    OpenUrl
  16. 16.↵
    1. Marin M. L.,
    2. Lee J. H.,
    3. Murtha J.,
    4. Ustunol Z.,
    5. Pestka J. J.
    Differential cytokine production in clonal macrophage and T-cell lines cultured with bifidobacteria. J. Dairy Sci. 80 1997 2713 2720
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Mestecky J.,
    2. Russell M. W.,
    3. Elson C. O.
    Intestinal IgA: novel views on its function in the defence of the largest mucosal surface. Gut 44 1999 2 5
    OpenUrlFREE Full Text
  18. 18.↵
    1. Miettinen M.,
    2. Vuopio-Varkila J.,
    3. Varkila K.
    Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun. 64 1996 5403 5405
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    1. Moreau M. C.,
    2. Corthier G.
    Effect of gastrointestinal microflora on induction and maintenance of oral tolerance to ovalbumin in C3H/HeJ mice. Infect. Immun. 56 1988 2766 2768
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Nakafuchi S.,
    2. Takahashi T.,
    3. Yajima T.,
    4. Kuwata T.,
    5. Hirayama K.,
    6. Itoh K.
    Strain dependency of the immunopotentiating activity of Lactobacillus delbrückii subsp. bulgaricus. Biosci. Biotechnol. Biochem. 63 1999 474 479
    OpenUrlCrossRefPubMed
  21. 21.↵
    1. Peng H. J.,
    2. Turner M. W.,
    3. Strobel S.
    The generation of a tolerogen after ingestion of ovalbumin is time dependent and unrelated to serum levels of immunoreactive antigen. Clin. Exp. Immunol. 81 1990 520 525
    OpenUrl
  22. 22.↵
    1. Pochart P.,
    2. Marteau P.,
    3. Bouhnik Y.,
    4. Goderle I.,
    5. Bourlioux P.,
    6. Rambaud J. P.
    Survival of bifidobacteria ingested via fermented milk during their passage through the human small intestine: an in vivo study using intestinal perfusion. Am. J. Clin. Nutr. 55 1992 78 80
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Saavedra J. M.,
    2. Bauman N. A.,
    3. Oung I.,
    4. Perman J. A.,
    5. Yolken R. H.
    Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhoea and shedding of rotavirus. Lancet 344 1994 1046 1049
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Salminen S.,
    2. Bouley C.,
    3. Boutron-Ruault M. C.,
    4. Cummings J. H.,
    5. Franck A.,
    6. Gibson G. R.,
    7. Isolauri E.,
    8. Moreau M. C.,
    9. Roberfroid M.,
    10. Rowland I.
    Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 80 1998 S147 S171
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Sarem-Damerji L. O.,
    2. Sarem F.,
    3. Marchal L.,
    4. Nicolas J. P.
    In vitro colonization ability of human colon mucosa by exogenous Lactobacillus strains. FEMS Microbiol. Lett. 131 1995 133 137
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Takahashi T.,
    2. Oka T.,
    3. Iwana H.,
    4. Kuwata T.,
    5. Yamamoto Y.
    Immune response of mice to orally administered lactic acid bacteria. Biosci. Biotechnol. Biochem. 57 1993 1557 1560
    OpenUrl
  27. 27.↵
    1. Takahashi T.,
    2. Nakagawa E.,
    3. Nata T.,
    4. Yajima T.,
    5. Kuwata T.
    Effects of orally ingested Bifidobacterium logum on the mucosal IgA response of mice to dietary antigens. Biosci. Biotechnol. Biochem. 62 1998 10 15
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Tejada-Simon M. V.,
    2. Ustunol Z.,
    3. Pestka J. J.
    Ex vivo effects of lactobacilli, streptococci, and bifidobacteria ingestion on cytokine and nitric oxide production in a murine model. J. Food Prot. 62 1999 162 169
    OpenUrlPubMedWeb of Science
  29. 29.↵
    1. Vasely R.,
    2. Nergi R.,
    3. Bianchi-Salvadori B.,
    4. Lavezzari D.,
    5. De Simone C.
    Influence of a diet additioned with yogurt on the mouse immune system. Immunopharmacology 51 1985 30 35
    OpenUrl
  30. 30.↵
    1. Weiner H. L.,
    2. Friedman A.,
    3. Miller A.,
    4. Khoury S. J.,
    5. Al-Sabbagh A.,
    6. Santos L.,
    7. Sayegh M.,
    8. Nussenblatt R. B.,
    9. Trentham D. E.,
    10. Hafler D. A.
    Oral tolerance: immunological mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu. Rev. Immunol. 12 1994 809 837
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Antiproliferative Effects of Homogenates Derived from Five Strains of Candidate Probiotic Bacteria
Tanja Pessi, Yelda Sütas, Maija Saxelin, Harri Kallioinen, Erika Isolauri
Applied and Environmental Microbiology Nov 1999, 65 (11) 4725-4728; DOI: 10.1128/AEM.65.11.4725-4728.1999

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Applied and Environmental Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Antiproliferative Effects of Homogenates Derived from Five Strains of Candidate Probiotic Bacteria
(Your Name) has forwarded a page to you from Applied and Environmental Microbiology
(Your Name) thought you would be interested in this article in Applied and Environmental Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Antiproliferative Effects of Homogenates Derived from Five Strains of Candidate Probiotic Bacteria
Tanja Pessi, Yelda Sütas, Maija Saxelin, Harri Kallioinen, Erika Isolauri
Applied and Environmental Microbiology Nov 1999, 65 (11) 4725-4728; DOI: 10.1128/AEM.65.11.4725-4728.1999
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Bifidobacterium
lactobacillus
Lactobacillus acidophilus
Lymphocyte Activation
probiotics
Streptococcus

Related Articles

Cited By...

About

  • About AEM
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #AppEnvMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

 

Print ISSN: 0099-2240; Online ISSN: 1098-5336